Pediatrix Medical Group Files Additional Proxy Materials

Ticker: MD · Form: DEFA14A · Filed: Mar 27, 2026 · CIK: 0000893949

Sentiment: neutral

Topics: proxy-filing, shareholder-materials

TL;DR

Pediatrix dropped more proxy docs, check 'em.

AI Summary

Pediatrix Medical Group, Inc. filed a DEFA14A on March 27, 2026, which includes additional definitive proxy soliciting materials. The filing contains 3 documents, including the main DEFA14A filing and two graphic files. The company's mailing and business address is 1301 Concord Terrace, Sunrise, FL 33323.

Why It Matters

This filing provides supplemental information to shareholders regarding matters to be voted on, impacting corporate governance and shareholder decisions.

Risk Assessment

Risk Level: low — This is a routine filing of additional proxy materials, not indicating any immediate financial or operational risk.

Key Players & Entities

FAQ

What type of filing is this DEFA14A?

This DEFA14A filing is for Additional definitive proxy soliciting materials and Rule 14(a)(12) material.

When was this filing accepted by the SEC?

The filing was accepted on 2026-03-27 at 06:52:03.

What is the CIK number for Pediatrix Medical Group, Inc.?

The CIK number for Pediatrix Medical Group, Inc. is 0000893949.

What is the business address of Pediatrix Medical Group, Inc.?

The business address is 1301 Concord Terrace, Sunrise, FL 33323.

How many documents are included in this submission?

There are 3 documents included in this submission.

Filing Stats: 494 words · 2 min read · ~2 pages · Grade level 9.4 · Accepted 2026-03-27 06:52:03

Filing Documents

From the Filing

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a-12 Pediatrix Medical Group, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No Fee Required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. LOGO P.O. BOX 8016, CARY, NC 27512-9903 Your vote matters! Pediatrix Medical Group, Inc. Annual Meeting of Shareholders Thursday, May 7, 2026 10:30 AM, Eastern Time Annual Meeting to be held live via the Internet - please visit www.proxydocs.com/MD for more details. You must register to attend the meeting online and/or participate at www.proxydocs.com/MD For a convenient way to view proxy materials, VOTE and obtain directions to attend the meeting go to www.proxydocs.com/MD To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before April 27, 2026. Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report or Form 10-K Important Notice Regarding the Availability of Proxy Materials for the Shareholders Meeting to be held on May 7, 2026 For Shareholders of record as of March 9, 2026 To order paper materials, use one of the following methods. Internet: www.investorelections.com/MD Call: 1-866-648-8affiliates. All Rights Reserved LOGO Pediatrix Medical Group, Inc. Annual Meeting of Shareholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1, 2, 3 AND 4 PROPOSAL 1. Elect n2026 fiscal year; 3. Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year; and 4. Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan 5. Consider and act upon such other business as may properly come before the annual meeting.

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing